Epithelioid sarcoma: a retrospective study of conservative treatment with initial surgery and radiotherapy

被引:4
作者
de Figueiredo, B. Henriques [1 ]
Kantor, G. [1 ]
Binh, M. Bui Nguyen [2 ]
Duparc, A. [1 ]
Guerder, C. [1 ]
Stoeckle, E. [3 ]
Coindre, J. M. [2 ]
Bui, B. N. [4 ]
机构
[1] Ctr Reg Lutte Canc, Inst Bergonie, Serv Radiotherapie, F-33076 Bordeaux, France
[2] Ctr Reg Lutte Canc, Inst Bergonie, Serv Pathol, F-33076 Bordeaux, France
[3] Ctr Reg Lutte Canc, Inst Bergonie, Serv Chirurg, F-33076 Bordeaux, France
[4] Ctr Reg Lutte Canc, Inst Bergonie, Med Oncol Serv, F-33076 Bordeaux, France
来源
CANCER RADIOTHERAPIE | 2007年 / 11卷 / 05期
关键词
epithelioid sarcoma; conservative surgery; radiotherapy;
D O I
10.1016/j.canrad.2007.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. - Epithelioid sarcoma is a rare type of soft tissue sarcomas with a high risk of recurrence both local and distant. The place of surgical conservative treatment and the role of radiation therapy remain controversial. Patients and methods. - A serie of 9 consecutive patients treated with initial conservative surgery and postoperative radiotherapy (median dose of 52.8 Gy) from 1987 to 2006 in the same institution was analyzed. Results. - With a median follow-up of 40 months (range 15-153 months), the rate of local, nodal and distant relapse is respectively 56%, 11% and 33%. The rate of death is 44.5%. No imputation has been performed. Conclusion. - Even with a high rate of local relapse observed, a conservative treatment doesn't seem to influence badly the overall survival (55.5% alive at 40 months). Indeed the rate of distant relapse and death are comparable with those found in the literature. Moreover relapse occurred almost within the irradiated volumes. An improvement of dose could be also discussed. (C) 2007 Elsevier Masson SAS. Tons droits reserves.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 46 条
[1]   EPITHELIOID SARCOMA - AN ANALYSIS OF 51 CASES [J].
BOS, GD ;
PRITCHARD, DJ ;
REIMAN, HM ;
DOBYNS, JH ;
ILSTRUP, DM ;
LANDON, GC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1988, 70A (06) :862-870
[2]   Epithelioid sarcoma: Results of conservative surgery and radiotherapy [J].
Callister, MD ;
Ballo, MT ;
Pisters, PWT ;
Patel, SR ;
Feig, BW ;
Pollock, RE ;
Benjamin, RS ;
Zagars, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (02) :384-391
[3]   EPITHELIOID SARCOMA - DIAGNOSIS, PROGNOSTIC INDICATORS, AND TREATMENT [J].
CHASE, DR ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (04) :241-263
[4]   Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group [J].
Coindre, JM ;
Terrier, P ;
Bui, NB ;
Bonichon, F ;
Collin, F ;
LeDoussal, V ;
Mandard, AM ;
Vilain, MO ;
Jacquemier, J ;
Duplay, H ;
Sastre, X ;
Barlier, C ;
HenryAmar, M ;
Lesech, JM ;
Contesso, G .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :869-877
[5]   Epithelioid sarcoma: Still an only surgically curable disease [J].
de Visscher, Sebastiaan A. H. J. ;
van Ginkel, Robbert J. ;
Wobbes, Theo ;
Veth, Rene P. H. ;
ten Heuvel, Suzanne E. ;
Suurmeijer, Albert J. H. ;
Hoekstra, Harad J. .
CANCER, 2006, 107 (03) :606-612
[6]  
ENZINGER FM, 1970, CANCER-AM CANCER SOC, V26, P1029, DOI 10.1002/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO
[7]  
2-R
[8]   MANAGEMENT OF EXTREMITY SOFT-TISSUE SARCOMAS WITH LIMB-SPARING SURGERY AND POSTOPERATIVE IRRADIATION - DO TOTAL-DOSE, OVERALL TREATMENT TIME, AND THE SURGERY-RADIOTHERAPY INTERVAL IMPACT ON LOCAL-CONTROL [J].
FEIN, DA ;
LEE, WR ;
LANCIANO, RM ;
CORN, BW ;
HERBERT, SH ;
HANLON, AL ;
HOFFMAN, JP ;
EISENBERG, BL ;
COIA, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (04) :969-976
[9]   Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution [J].
Gronchi, A ;
Casali, PG ;
Mariani, L ;
Miceli, R ;
Fiore, M ;
Lo Vullo, S ;
Bertulli, R ;
Collini, P ;
Lozza, L ;
Olmi, P ;
Rosai, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :96-104
[10]  
Halling AC, 1996, MAYO CLIN PROC, V71, P636